Vyvanse, or its generic counterpart lisdexamfetamine dimesylate, is prescribed to treat ADHD in adults, and children six years of age or older, as well as moderate to sever binge eating disorder (BED) ...

Teva Pharmaceutical Industries Limited has successfully shifted its strategy, leveraging its generics business to fund growth in specialty medicines, driving a turnaround in performance. TEVA's "Pivot ...

Q. I am dealing with a horrible decline from generic Wellbutrin XL. I’ve been on samples of the name brand and my symptoms slowly improved. The generic is definitely a problem. My insurance won’t ...

Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...

WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups and ...

Oct 2 (Reuters) - The U.S. Food and Drug Administration has approved Evita Solution's generic version of the abortion drug, mifepristone, the regulator said. The FDA said in a letter dated September ...

Generics of Gilead Sciences' twice-yearly HIV pre-exposure prophylaxis (PrEP) Yeztugo (lenacapavir) are on the horizon, with India's Dr. Reddy’s Laboratories and Hetero Labs striking separate ...

This repository contains the complete research materials, implementation examples, benchmarks, and documentation for our academic paper on C++23 reflection and metaclasses. The project demonstrates ...

The Association for Accessible Medicines and the Biosimilars Council have released the 2025 U.S. Generic & Biosimilar Medicines Savings Report. AAM’s annual savings report highlights that generic and ...

Liraglutide, a generic of Saxenda, is approved to treat adults and adolescents who are obese or overweight. Teva Pharmaceuticals has received FDA approval and has launched a generic version of Saxenda ...

July 9 (UPI) --The Hims & Hers wellness platform announced Wednesday it will soon offer a generic version of the weight loss drug semaglutide in Canada as Novo Nordisk's patent on its branded version, ...